← Insider buys
RETA

Reata Pharmaceuticals Inc

Chief Research Officer Colin John Meyer sold $4.4M of Reata Pharmaceuticals Inc

Sold$4,375,000
$175.00Price
25,000Shares
−26%Stake

What RETA did after the filing

Prices for RETA after this filing aren't in yet.

Traded Mon, Nov 9. Filed Tue, Nov 10, 12:59 PM ET, during the session. Not investment advice.